Follistatin 344 has a limited human safety profile. The gene therapy data (Minicircle, 500+ patients) reported zero serious adverse events at 3 months. The most common effect was a slight LDL cholesterol increase of 8 mg/dL in approximately one-third of patients.
Reported side effects from practitioner protocols:
Side Effect Frequency Severity Management Injection site redness/swelling Common Mild Rotate injection sites LDL cholesterol elevation ~33% Mild (8 mg/dL average) Monitor lipids, consider diet adjustment Mild fatigue during cycle Occasional Mild Transient, resolves off-cycle Joint discomfort Rare Mild May indicate rapid muscle growth outpacing connective tissue
The danger you cannot see in the vial. Sourcing peptides safely is critical. For guidance on evaluating suppliers, see where to buy peptides in 2026. You buy follistatin online. Nearly half of tested products (9 out of 17 in a WADA-funded analysis) contained degraded or mislabeled material (PubMed 31758732). You inject what might be nothing, or worse, an unknown protein. Sourcing from reputable suppliers with third-party certificates of analysis is not optional; it is the only way to know what is actually in your syringe.
The danger you will notice too late. Eleven bodybuilders using high-dose follistatin 344 developed central serous chorioretinopathy (CSCR), a condition where fluid builds up under the retina, distorting and blurring your vision. Average recovery: 2.3 months of impaired sight. Recurrence was observed in patients who resumed follistatin. The authors concluded that follistatin-344 injection should be considered a risk factor for CSCR (Dag et al. 2020, PubMed 32671599). If you experience any visual changes, stop immediately and see an ophthalmologist.
Fertility impact: Follistatin inhibits pituitary FSH (follicle-stimulating hormone) release. In women, FSH drives ovarian follicle development. In men, FSH supports spermatogenesis. Artificially elevated follistatin may suppress FSH and impair your fertility during the cycle. This effect should reverse off-cycle, but if you and your partner are actively trying to conceive, avoid follistatin entirely. The Kota 2009 primate study found no permanent reproductive effects, but short-term suppression was not measured (PubMed 19208403).
Activin suppression beyond muscle: Activin regulates wound healing, immune function, and erythropoiesis (red blood cell production). Broadly suppressing activin signaling could have effects beyond muscle. Follistatin's isoform-specific distribution provides some protection, but high-dose exogenous follistatin may override this selectivity.
WADA status: Follistatin is listed on the World Anti-Doping Agency (WADA) Prohibited List under S4.3 (Metabolic Modulators). If you are subject to anti-doping testing, you must not use follistatin in any form. Testing methods can detect both the recombinant protein and evidence of gene therapy delivery.
Follistatin 344 should not be used by individuals with active cancer, as myostatin inhibition may theoretically promote tumor growth in certain contexts. If you have cardiovascular disease, liver disease, or hormonal conditions, consult a physician before use. For a broader overview of peptide safety considerations, see our peptide safety guide.